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Abstract
High–fat (HF) diet-induced obesity and insulin insensitivity are associated with inflammation, particularly in white adipose
tissue (WAT). However, insulin insensitivity is apparent within days of HF feeding when gains in adiposity and changes in
markers of inflammation are relatively minor. To investigate further the effects of HF diet, C57Bl/6J mice were fed either a
low (LF) or HF diet for 3 days to 16 weeks, or fed the HF-diet matched to the caloric intake of the LF diet (PF) for 3 days or 1
week, with the time course of glucose tolerance and inflammatory gene expression measured in liver, muscle and WAT. HF
fed mice gained adiposity and liver lipid steadily over 16 weeks, but developed glucose intolerance, assessed by
intraperitoneal glucose tolerance tests (IPGTT), in two phases. The first phase, after 3 days, resulted in a 50% increase in area
under the curve (AUC) for HF and PF mice, which improved to 30% after 1 week and remained stable until 12 weeks.
Between 12 and 16 weeks the difference in AUC increased to 60%, when gene markers of inflammation appeared in WAT
and muscle but not in liver. Plasma proteomics were used to reveal an acute phase response at day 3. Data from PF mice
reveals that glucose intolerance and the acute phase response are the result of the HF composition of the diet and
increased caloric intake respectively. Thus, the initial increase in glucose intolerance due to a HF diet occurs concurrently
with an acute phase response but these effects are caused by different properties of the diet. The second increase in
glucose intolerance occurs between 12 - 16 weeks of HF diet and is correlated with WAT and muscle inflammation. Between
these times glucose tolerance remains stable and markers of inflammation are undetectable.
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Introduction
Obesity and related metabolic disorders are largely the result of
overconsumption of energy dense foods, high in sugar and long
chain saturated fats. Diet-induced obesity leads to insulin
insensitivity and numerous studies have shown that obesity and
insulin insensitivity are related to the presence of low-grade
inflammation [1,2]. Further evidence for the role inflammation
plays in obesity comes from studies where inflammation is either
inhibited, leading to the prevention of insulin insensitivity and
reductions in weight gain [3–5], or the inhibition of anti-
inflammatory pathways which increases weight gain and the
development of the metabolic syndrome [6]. While it is well
established that dietary long chain saturated fatty acids cause
insulin insensitivity and obesity [7], there is some debate as to the
role of lipid induced increases in gut permeability and subsequent
leakage of gut bacterial lipopolysaccharide (LPS) [8], as opposed to
the role of lipid overload and ectopic fat deposition [9,10] in
obesity related inflammation.
Most studies have focused on the development of obesity and
insulin insensitivity in rodent models of either genetic or diet-
induced obesity after several weeks on a HF diet. These studies
have shown that insulin insensitivity is related to cellular
inflammation involving the JNK1 and IKKb-NFkB cascade
[11,12], while relatively few studies have focused on the rapid
induction of insulin insensitivity seen within 1 week of HF diet.
Nonetheless, studies of early responses to a HF diet are emerging
with one study showing that insulin insensitivity after 1 week of HF
diet in the C57Bl/6 mouse is the consequence of insulin
insensitivity in the vascular endothelium [13], and another
demonstrating that hypothalamic markers of inflammation are
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activated between 1 and 3 days on a HF diet [14]. One study
looking at both short- and long-term HF diet induced insulin
resistance found inflammation increased from day 1 of HF feeding
onwards [15], but concluded after looking at the response to HF
diet in three different immuno-compromised mouse models, that
inflammation was not necessary for the development of short-term
but necessary for long-term insulin resistance [15]. More recently,
inflammation in WAT was shown to contribute to the early
induction of insulin insensitivity [16], while in contrast a separate
study argued for the role of lipid metabolite accumulation in
tissues early in HF feeding [17]. Other studies using transcriptomic
approaches have identified early inflammation in the liver together
with gradually increasing inflammation in WAT after HF feeding
in mice [18,19]. Indeed, Kupffer cell activation has been
demonstrated after 3 days on a HF diet and Kupffer cell ablation
at this time can prevent the associated hepatic insulin insensitivity
and reduce adiposity [20]. However, if ablation of Kupffer cells
takes place after macrophage infiltration of WAT is established it
does not improve metabolic health [21], arguing for a role of liver
inflammation in the early, but not later, development of insulin
insensitivity and adiposity.
In the present study we hypothesised that the initial stages of
glucose intolerance are induced by the HF composition of the diet.
Thus, our aim was to further investigate the timeline of the
induction of glucose intolerance and inflammation, particularly
the early, within days, response to a HF diet. We used plasma
proteomics to detect what, if any, changes in major plasma
proteins occurred and identified a transient acute phase response
at this time. Furthermore, mice fed the HF diet matched to the
caloric intake of the LF fed mice (PF) demonstrated that glucose
intolerance seen after 3 days is attributable to diet composition in
comparison to the high levels of acute phase proteins seen at 3
days which are attributable to the additional calories in the diet. In
summary, our data show a rapid, transient induction of relatively
high levels of glucose intolerance coincident with an acute phase
response but these two physiological events appear to be caused by
different mechanisms in C57Bl/6 mouse fed a HF diet. The peak
in glucose intolerance seen within 3 days of HF diet is followed by
a relative improvement in glucose tolerance which remains stable
between 1 and 12 weeks on HF diet with undetectable levels of
inflammation in most organs until between 12 and 16 weeks when
gene markers of inflammation become apparent in WAT and
muscle, but not in liver, and the animals become more glucose
intolerant. These data argue that glucose intolerance and
inflammation do not increase gradually on a HF diet but occur
in distinct phases.
Methods
Ethics statement
All studies involving animals were licensed under the Animal
(Scientific Procedures) Act of 1986 and had received approval
from the Rowett Institute of Nutrition and Health’s Ethical
Review Committee.
Animals
Male C57BL/6 mice, 12 weeks of age and lacking mutations in
the NNT gene, which may result in impaired insulin secretion
[22], (Harlan, Bicester, UK), were singly housed on grid floors and
either fed a HF (60% of energy from fat and 5.2 kcal/g) or a LF
diet (10% of energy from fat and 3.8kcal/g) (D12492 and
D12450B, respectively; Research Diets, NJ, US) ad libitum for
either 3 days or 1, 4, 8, 12 or 16 weeks. Please see http://www.
researchdiets.com/opensource-diets/stock-diets/dio-series-diets for
diet composition details. Also additional groups of mice were pair-
fed the HF diet restricted to the caloric intake of the LF fed animals
for 3 days or 1 week (PF). LF fed mice eat on average 3.18 g/day/
mouse and HF fed mice eat 2.9 g/day/mouse. Thus, PF mice were
given 2.3 g/day/mouse of the HF diet to match the caloric intake to
that of LF fed mice. Single housing and grid floors were utilised to
enable accurate measurement of food intake, to prevent copropha-
gia and stress due to dominance. However, it is recognised that
single housing of mice may in itself cause stress and this is alleviated
to a certain extent by the provision of environmental enrichment
and housing mice close to each other. The design of the study
recognises that at different ages mice will show different levels of
gene expression and may react differently to diet composition. Food
intakes and body weights were measured twice weekly and MRI
scans (EchoMRI, Houston, TX, USA), providing body composition
of conscious mice, were carried out at the beginning of the study, at
3 days, and weekly thereafter (n= 8–12).
Glucose tolerance
Intraperitoneal glucose tolerance tests (IPGTTs) were carried
out (n = 6–8) as a non-recovery procedure after fasting for 5 hours.
A blood sample (0 mins) was taken prior to the intraperitoneal IP
glucose injection (1.5 mg/g body weight). Subsequent blood
samples were taken from the tail vein at 15, 30, 60 and 120 mins
and measured using an Accu chek Aviva blood glucose monitor
(Roche Diagnostics, Burgess Hill, UK). Area under the curve
(AUC) was calculated by using the trapezoid rule [23].
Immunohistochemistry
A separate group of animals were killed by cardiac puncture
under terminal anaesthesia induced by Euthatal (sodium pheno-
barbital) at a concentration of 500 mg/Kg injected IP. Liver,
epididymal WAT and the gastrocnemius muscles were fixed in 4%
paraformaldehyde for immunohistochemistry and/or oil red O
staining (n = 6–8). Tissue was frozen and cryosections cut for oil
red O staining. For immunohistochemistry tissues were wax
embedded, sections were cut and dewaxed before staining with a
rat anti mouse F4/80 antibody (AbD Serotec, Kidlington, UK).
Further steps were carried out using the Vectastain Elite ABC Kit
according to the manufacturer’s instructions (Vector Laboratories,
Peterborough, UK). Analysis of microscope images was carried out
Figure 1. A. Body weight of the HF fed mice differed significantly from those of the LF fed mice from 3 days of feeding (P,0.01) and (P,0.001)
onwards. B. The increase in body weight seen in A is mostly fat mass which was increased in the HF mice from 3 days onwards (P,0.001). C. Mean
food intake of mice receiving either a LF or HF diet (grams per day). The intake of the HF fed mice was decreased at 3 days on diet (P,0.01) and (P,
0.001) thereafter (n = 6–8). D. PF animals showed a decrease in body weight after 3 days on diet compared to LF (P,0.05 and HF fed animals (P,
0.001). E. PF animals had a similar body weight to LF fed mice after 1 week on diet. Both LF and PF mice had lower body weight than the HF mice (P,
0.001). F. Body fat measured by MRI after 3 days of diet was increased in PF (P,0.05) and HF mice (P,0.001) compared to LF mice despite the lower
body weight seen in PF mice in C. G. Body fat after 1 week on diet was higher in both PF (P,0.001) and HF fed mice (P,0.001) compared to LF and
was also higher in HF (P,0.001) compared to PF mice. H. Lean body mass after 3 days on diet was similar in all mice LF, PF and HF indicating that all
weight changes were due to changes in adiposity. I. Lean mass after 1 week on diet was only increased in HF fed mice compared to LF and PF (P,
0.001) (n = 6–8).
doi:10.1371/journal.pone.0106159.g001
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using an Image Pro-plus system (Media Cybernetics, Silver
Springs, MD, USA).
Real-time PCR assays
Tissues were frozen in liquid nitrogen for real-time PCR. Total
RNA was extracted from liver, WAT and ileum using an RNeasy
Mini Kit (Qiagen, Crawley, UK) incorporating DNase digestion.
Total RNA was isolated from gastrocnemius muscle using TRIzol
reagent (Invitrogen/Life Technologies, Carlsbad, CA, US).
Extracted total RNA was quantified using a NanoDrop Spectro-
photometer (NanoDrop Technologies). Quality was assessed using
an Agilent Bioanalyser (Agilent Technologies).
Complementary cDNA templates for real-time PCR assays
were prepared from Superscript II (Invitrogen) reverse transcribed
total RNA (0.5–2.5 mg). Taqman real-time PCR assays were
performed using VIC and FAM reporter dyes. Taqman primer
assays for B2M (Mm00437762_m1), 18S (part no. 4319413E), b-
actin (ACTB) (Mm00607939_s1), GAPDH (Mm99999915_g1),
haptoglobin (Mm00516884_m1), CXCL1 (Mm00433859_m1),
F4/80 (Mm00802529_m1), MRC-1 (Mm00485148_m1), ARG
(Mm00475988_m1),ITgax (Mm00498698_m1),IL-10 (Mm004439614
_m1), APOA4 (Mm00431814_m1), IL-6 (Mm99999064_m1), IL-
1b (Mm00434228_m1) and CXCL1 (Mm0433859_m1), TNFa
(Mm00443258_m1), SAA (Mm04208126_mH) supplied by Ap-
plied Biosystems were used to assess gene expression in liver and
ileum using 10 ml Taqman Fast Universal PCR 2x mastermix No
AmpErase UNG (Applied Biosystems, UK) according to the
manufacturer’s instructions. SYBR real-time PCR analysis of
serpinA3N was performed using Superarray Bioscience Corpora-
tion SYBR green master mix and specific primer pairs for
serpinA3N (PPM05779F) (Qiagen, UK), according to the manu-
facturer’s instructions. Real-time PCR assays were performed using
the ABI-7500Fast (Applied Biosystems, UK). A two-step cycling
programme of 95uC 20 seconds, then 40 cycles of 95uC for 3 sec
and 60uC for 30 sec was used for Taqman assays and an initial step
of 10 minutes at 95uC to activate the HotStart DNA polymerase,
followed by 40 cycles of 15 seconds at 95uC and 1 minute at 60uC
for SYBR assays. The threshold cycle number (Ct) was measured
using the ABI7500Fast associated software (Applied Biosystems).
For assessment of gene expression in gastrocnemius muscle
TaqMan probes were designed from the Universal ProbeLibrary,
ProbeFinder version 2.45 for mouse (Universal ProbeLibrary,
Roche). Primer sequences were; GAPDH forward 59-CCTTGA-
GATCAACACGTACCAG-39, reverse; 59-CGCCTGTACACT-
CCACCAC-39; TNF-a forward 59-CTGTAGCCCACGTCG-
TAGC-39, reverse 59-TTGAGATCCATGCCGTTG-39; IL-6
forward 59-GCTACCAAACTGGATATAATCAGGA- 39, re-
verse 59-CCAGGTAGCTATGGTACTCCAGAA-39; IL-1b for-
ward 59- TGTAATGAAAGACGGCACACC-39, reverse 59-
TCTTCTTTGGGTATTGCTTGG-39; and were purchased
from Sigma-Aldrich (Gillingham, Dorset, UK), The reactions
were carried out in using 10 ml LightCycler 480 Probes MasterMix
according to the manufacturer’s instructions. Real time PCR
assays were performed using the LightCycler 480 system (Roche
Diagnostics, Mannheim, Germany). The cycling programme
consisted of a pre-incubation of 10 min at 95uC followed by 45
cycles consisting of a 10 seconds at 95uC, and 30 seconds at 60uC.
The Ct number was measured using the Lightcycler 480 system
version 5 software (Roche Diagnostics, Mannheim, Germany).
Transcript levels relative to the reference gene, GAPDH in
muscle and ileum, and B2M in liver and WAT were calculated
(DCt). Fold expression changes between experimental groups
relative to GAPDH or B2M were calculated from the DDCt values
(n = 6–8). As these values are ratios there are no standard errors.
Two-dimensional gel electrophoresis (2-DE)
The 2-DE was performed essentially as detailed previously with
some modifications [24]. Bio-Rad, 11 cm, immobilized pH
gradient (IPG) strips (pH 3–10) were used for the separation of
plasma proteins in the first dimension. Strips were rehydrated in
rehydration buffer (7 M urea; 2 M thiourea; 4% w/v CHAPS; 2%
w/v Biolyte; and 50 mM DTT) containing 200 mg of protein
sample in a Bio-Rad IEF cell and then focused.
After the first dimension IPG strips were incubated in fresh
equilibration buffer (6 M urea; 2% w/v SDS; 0.375 M Tris-HCl,
pH 8.8; 20% v/v glycerol; and 130 mM DTT) for 10–15 min at
room temperature before transfer to a second equilibration buffer
(6 M urea; 2% w/v SDS; 0.375 M Tris-HCl, pH 8.8; 20% v/v
glycerol; and 135 mM iodoacetamide) for 10–15 min at room
temperature. The strip was then applied to the top of a precast
Criterion XT Bis-Tris 3–12% IPG+1 well gel cassette and 5 ml of
All Blue Precision Protein Standards (Bio-Rad) was loaded in the
reference well. Gels were run at 200 V until the bromophenol blue
had reached the bottom of the gel. The gels were fixed and stained
with Coomassie Blue (n = 5).
Identification of mouse plasma proteins
The 2-DE gels were analysed using Progenisis Samespots
software (Nonlinear Dynamics Ltd, UK). Spots which showed
differences in normalised average volume with P,0.05 by Anova
in HF vs. LF were cut from SDS-PAGE gels. Gel plugs were
trypsinized using the MassPrep Station (Waters, Micromass, UK)
protocol. Spot identification was carried out by LC/MS/MS as
described previously [24] using an ‘Ultimate’ nanoLC system (LC
Packings, UK) and a Q-Trap (Applied Biosystems/MDS Sciex,
UK) triple quadrupole mass spectrometer fitted with a nanospray
ion source. The total ion current (TIC) data were submitted for
database searching using the MASCOT search engine (Matrix
Science, UK) using the MSDB database.
Western blot analysis
Mouse plasma samples were separated by electrophoresis as
reported previously [24]. Bands on the blots from LF fed animals
were considered as equivalent to 1 and those from HF animals
scored accordingly. Mouse plasma samples containing 10 mg of
total plasma protein were separated by electrophoresis using
precast Criterion XT Bis-Tris Gels (Bio-Rad). Following electro-
phoresis the gels were either stained using Simply Blue Safe Stain
Figure 2. A, B &C. Liver lipid measured by image analysis of oil red O in arbitrary units (AU). A. staining increased linearly with time on diet in HF fed
mice from 1 week (P,0.001) onwards. Representative images of oil red O stained sections for HF and LF fed mice after 8 weeks on diet. Mag X 100. B.
Liver lipid in PF mice was reduced compared to both LF and HF mice after 3 days (P,0.01). There was no difference in liver lipid between LF and HF
fed mice. C. After 1 week on diet there was no difference in liver lipid between LF and PF mice but HF mice had more lipid than LF (P,0.001) and PF
(P,0.01) mice (n = 6–8). D & E. Liver (TAG), measured by Kone analysis. D. LF and HF levels are not significantly different while PF mice show a lower
level of TAG compared to LF fed mice (P,0.05) after 3 days on diet. E. LF and HF levels are not significantly different while PF mice show a lower level
of TAG compared to LF fed mice (P,0.05) after 1 week on diet.
doi:10.1371/journal.pone.0106159.g002
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(Invitrogen, UK) to verify protein loading or the proteins were
transferred onto PVDF membranes [24] and protein transfer was
confirmed by Ponceau red staining. The membranes were then
probed with the following primary antibodies; haptoglobin
antibody (ab8968) (AbCam, Cambridge, UK), ApoA-IV(N20)
antibody (Santa Cruz Biotechnology, Dallas, US) and mouse
serpinA3N antibody (R&D Systems, Abingdon, UK). Following
incubations with the primary antibodies the membranes were
incubated with secondary antibodies conjugated to HRP (Ab-
Cam). The blots were then developed using chemiluminesent
detection reagent (Merck Millipore, Feltham, UK) and imaged
using the FujiFilm LAS-3000 system. The resulting gel and blot
bands were then analysed using TotalLab software (Nonlinear
Dynamics, UK). Bands on the blots from LF fed animals were
considered as equivalent to 1 and those from HF animals scored
accordingly (n = 6–8).
Measurement of plasma hormones
Measurements were carried out using Luminex’s xMAP
Technology and Milliplex MAP mouse serum adipokine panel
for insulin and leptin and Milliplex MAP mouse cytokine/
chemokine panel for IL-1b, IL-6 and TNFa (Merck Millipore,
Feltham, UK). All measurements were carried out on terminal
blood samples from fed animals (n = 6–8).
Measurement of plasma lipids
Analyses were carried out on terminal blood samples from fed
mice (n = 6–8) using a Thermo Konelab 30 clinical analyser and
kits for HDL and LDL cholesterol and (Microgenics GmbH
Passau, Germany) and non-esterified fatty acid (NEFA) (Alpha
Laboratories Eastleigh, UK).
Statistical Analysis
Data are represented as mean 6 SEM and were analyzed using
GenStat (GenStat, 10th Edition, VSN International Ltd, Oxford).
In the case of experiments testing the influence of a single factor a
one-way ANOVA was performed. Where two factors were
involved data were analysed by two-way ANOVA. P,0.05 was
considered statistically significant.
Results
Body Weight and Composition
Body weight and adiposity of mice fed a HF diet were
significantly increased after 3 days on diet and both continued to
increase linearly with time compared to the LF fed mice (Fig 1A–
B). Food intake dropped significantly in HF fed mice at day 3 on
the diet and this lower level was maintained (Fig 1C). PF mice
showed a drop in body weight after 3 days compared to both LF
and HF diets (Fig 1D), after 1 week body weight was similar in the
LF and PF groups which were both lower that the HF fed mice
(Fig 1E). Despite a lower body weight after 3 days on the diet the
PF mice have increased adiposity compared to the LF fed mice
(Fig 1F). By 1 week on diet the PF mice have further increased
adiposity compared with the LF mice (Fig 1G) and have a lower
lean mass compared to HF fed animals (Fig 1I). There were no
difference in lean mass at 3 days or 1 week between LF and HF fed
mice (Fig 1H & I).
Liver and Circulating Lipids
Liver lipid, measured by oil red O, increased linearly (Fig 2A)
but was not significantly increased after 3 days on HF diet. Liver
lipid measured by oil red O was lower in the PF mice compared to
the LF after 3 days (Fig 2B). By 1 week on diet there was no
difference in liver lipid between LF and PF animals but HF
animals had higher levels of liver lipid, measured by oil red O,
than PF or LF mice (Fig 2C). Liver triacylglycerol (TAG) levels,
measured by Kone analysis, showed a reduction in liver TAG after
3 days in the PF mice and no difference between LF and HF mice
at this time (Fig 2D). Liver TAG, measured by Kone analysis, after
1 week showed lower levels in PF mice compared to HF mice but
no difference between LF and HF mice (2E). Plasma triacylgly-
cerol (TAG) levels were significantly lower in the HF fed mice at 3
days and 1 week and was unchanged after 16 weeks on HF diet
(Fig 3A). Plasma non esterified fatty acids (NEFA) levels were
unchanged at all times tested (3B). Liver TAG levels were
unchanged in the HF fed mice at 3 days and 1 week and
significantly higher after 16 weeks on HF diet (Fig 3C). Liver
NEFA levels were unchanged at 3 days and 1 week on HF diet but
were significantly lower after 16 weeks on HF diet (Fig 3D). Serum
LDL and HDL cholesterol were elevated in HF fed mice at 3 days
and again at 16 weeks but were unchanged at 1 week on HF diet
(Fig 3E.&F).
Glucose tolerance
Total AUC was increased in HF fed mice at all the time points
tested (Fig 4A–D). When the % difference in AUC between LF
and HF fed mice was compared for all time points, tested using a
two-way ANOVA for diet and time interaction, there were
significant effects of both diet (P,0.01) and time (P,0.01) and an
interaction between diet and time (P,0.05). However, when the 3
day and 16 week data were excluded from the analysis there was
no significant difference between total AUC at the individual time
points of 1, 4, 8 and 12 weeks on the HF diet showing that glucose
intolerance remained stable between these times (Fig 4E). Glucose
tolerance after 3 days on diet showed that both PF and HF mice
had a similar AUC which was higher than the LF mice (Fig 4F).
By 1 week on diet the PF mice had similar AUC to the LF mice
and HF mice had a higher AUC than both (Fig 4G).
Circulating leptin, insulin and basal glucose levels
Circulating leptin levels were increased after both 3 days (P,
0.05) and 16 weeks (P,0.001) on the HF diet but not after 1 week
(Fig 5A). Insulin levels were unchanged at 3 days and 1 week on
HF diet but were significantly increased after 16 weeks (P,0.05)
(Fig 5B). There was a large variability in insulin levels measured as
animals in this study were not fasted. Basal fasted glucose levels in
HF mice compared to LF approached significance after both 3
days (P=0.08) and 1 week (P=0.052) on diet but were not
different after 16 weeks. Fasted glucose levels in PF mice were
Figure 3. A. Plasma triacylglycerol (TAG) was significantly lower in HF fed mice at both 3 days and 1 week on diet (P,0.001), but did not differ at 16
weeks on diet. B. Plasma non esterified fatty acids (NEFA)/free fatty acids were unchanged by a HF diet at all times tested. C. Liver TAG levels were
unchanged in the HF fed mice at 3 days and 1 week and significantly higher after 16 weeks on HF diet (P,0.05). D. Liver NEFA levels were unchanged
at 3 days and 1 week on HF diet but were significantly lower after 16 weeks on HF diet (P,0.001) E. Plasma low-density lipoprotein (LDL) cholesterol
was elevated in HF fed mice after 3 days (P,0.01) and 16 weeks (P,0.001) on diet, but was not different from LF values after 1 week. F. Plasma high-
density lipoprotein (HDL) cholesterol followed the same pattern as LDL cholesterol and was higher in HF fed mice at 3 days (P,0.01) and 16 weeks
(P,0.001) on diet, but was not different from LF after 1 week of diet (n = 6–8).
doi:10.1371/journal.pone.0106159.g003
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Figure 4. A–D. Intraperitoneal glucose tolerance tests (IPGTT) in LF fed miceN, HF fed miceN and PF fed mice&, fed the HF diet restricted to the
caloric intake of the LF fed mice, after 3 days, 1, 12 and 16 weeks after the start of diet. IPGTT was carried out as a non-recovery procedure as the
effect of fasting and glucose administration can alter gene expression for some time afterwards. (n = 6–8). E. Comparison of the % difference in total
AUC between LF and HF mice over time using a two-way ANOVA showed that when time points 3 days and 16 weeks were included that diet and
time had a significant effect on glucose tolerance (F1,58 = 94.56, P,0.01) and (F4,58 = 11.22, P,0.01) respectively and that there was an interaction
between diet and time (F4,58 = 2.83, P,0.05). However, when these time points were omitted there was no effect of time or diet indicating that there
was no change in AUC between 1 and 12 weeks. One way ANOVA of the difference between LF and HF total AUC revealed that is was higher at 3
days (P,0.01) and 16 weeks (P,0.01) compared to the other time points tested and that there was no change in the % difference in total AUC
between 1, 4, 8 and 12 weeks on diet. F. A comparison of total AUC in LF, PF and HF fed mice after 3 days on diet shows the PF (P,0.05) and HF (P,
0.01) mice have higher total AUC compared to LF mice but that the total AUC for PF and HF was not significantly different (NS). G. A comparison of
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significantly lower than LF and HF fed mice (P,0.05) at 3 days
and 1 week on diet which may be indicative of a more prolonged
fasting period than that imposed on the other mice (Fig 5C).
Plasma proteomics and Western blotting
Analysis of 2-DE revealed a total of 28 soluble proteins, from a
total of 247, that were significantly changed between the LF and
HF fed mice after 3 days on diet (Fig 6). These were analysed by
LC-MS/MS and the majority were classified as acute phase
proteins (Table 1). To extend these findings, two typical acute
phase proteins; haptoglobin and alpha-1-antichymotrypsin
(aACT) and one atypical acute phase protein, ApoA-IV were
measured by Western blotting to confirm their up-regulation in
the HF-fed animals. After 3 days on diet (Fig 7A), all proteins were
increased compared with the LF control. After 1 week on the diet
the levels of haptoglobin and aACT had dropped but ApoA-IV
remained elevated (Fig 7B). After 16 weeks on the HF diet only
haptoglobin was elevated (Fig 7C). In plasma from PF mice levels
total AUC in LF, PF and HF fed mice after 1 week on diet shows a different pattern with no difference in total AUC between LF and PF mice (NS). The
total AUC for HF mice is significantly higher than PF (P,0.01) and LF mice (P,0.05) (n = 6–8).
doi:10.1371/journal.pone.0106159.g004
Figure 5. A. Plasma leptin levels were significantly higher in HF fed mice after 3 days on diet (P,0.05), did not differ after 1 week on diet (NS) and
increased greatly after 16 weeks on HF diet (P,0.001). B. Plasma insulin levels were not different in HF mice compared to LF fed mice after 3 days or 1
week on diet (NS) but were increased after 16 weeks (P,0.05). C. Fasted glucose levels approached statistical significance for HF vs. LF after 3 days
and 1 week on diet (P= 0.08 and P= 0.052 respectively) but was not different at 16 weeks. Fasted glucose in PF mice was significantly lower than LF
mice at both 3 days and 1 week of feeding (P,0.05) (n = 6–8).
doi:10.1371/journal.pone.0106159.g005
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of haptoglobin and aACT were comparable with mice on a LF
diet at 3 days and 1 week, while levels in the HF animals were
significantly elevated after 3 days on diet. After 1 week on the diets
only the ApoA-IV showed an up-regulation in both the PF and HF
groups compared to the LF (Fig 7D–F).
Inflammatory markers in the plasma
Plasma levels of IL-6 were increased in HF fed mice after 3 days
on diet (P,0.05) (Fig 8A). Plasma levels of TNFa and IL-1b were
not significantly different between HF and LF mice at any of the
time points measured but showed large variability in circulating
levels particularly in the HF fed mice at day 3 (Fig 8B&C).
Acute phase protein gene expression in liver and ileum
The expression of acute phase protein genes in the liver on the
HF diet was elevated for serpinA3N (the gene encoding aACT) at
3 days, 1 week and 16 weeks, haptoglobin at 1 week and 16 weeks
and serum amyloid A at 3 days and 1 week, however, the level of
up-regulation varied (Fig 9A–C). In contrast to circulating levels,
gene expression of ApoA-IV in the liver was significantly down-
regulated in HF compared to LF animals at day 3 and 1 week on
the HF diet and were not different at week 16 (Fig 9D). However,
ApoA-IV gene expression in the ileum was significantly up-
regulated at all three times tested (Fig 9E). SerpinA3N gene
expression showed variation with time on diet with down-
regulation at 16 weeks compared with 3 days on LF diet (Fig 9F).
Figure 6. Representative 2D Coomassie stained gel of mouse plasma after 3 days on the HF diet. Bio-Rad, 11 cm, immobilized pH
gradient (IPG) strips (pH 3–10) were used for the separation of plasma proteins in the first dimension. After the first dimension the IPG
strip was applied to the top of a precast Criterion XT Bis-Tris 3–12% IPG+ 1 well gel cassette and 5 ml of All Blue Precision Protein Standards (Bio-Rad)
were loaded in the reference well. The gels were fixed and stained with Coomassie Blue. Numbered spots indicate those with significantly different
average normalised volumes (P,0.05) (n = 5) in HF compared to LF mice. Proteins were identified by LC/MS/MS. Spots inside dotted lines have been
identified as the same protein. See Table 1 for protein identification.
doi:10.1371/journal.pone.0106159.g006
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Macrophage area and inflammatory marker gene
expression in liver
The area occupied by liver Kupffer cells, measured by F4/80
immunohistochemistry, was increased in the HF fed mice
compared to the LF at all time points tested and the increase in
area appeared to peak at 4 weeks on HF diet, but did not increase
further (Fig 10A). Gene expression of both pro- and anti-
inflammatory markers, including IL-1b, IL-6, TNFa, CXCL1,
F4/80, ARG and ITgax in the liver showed no differences at 3
days, 1 week or 16 weeks on a HF diet (data not shown). IL-10
expression was not detectable in the liver (data not shown).
However, MRC-1, an anti-inflammatory marker, was down-
regulated in HF compared to LF mice after 3 days on diet
(Fig 10B). IL-1b expression showed a difference over time on the
LF diet with an up-regulation between 3 days and 16 weeks
(Fig 10C). TNFa did not show an increase in expression over time
between 3 days and 16 on the LF diet (Fig 10D).
Inflammatory marker gene expression in muscle
Both IL-1b and IL-6 gene expression were up-regulated in
muscle at 12 and 16 week in HF compared to LF fed mice (Fig 11
Figure 7. A. Plasma protein levels of haptoglobin (P,0.05), alpha-1-antichymotrypsin (aACT) (P,0.01) and ApoA-IV (P,0.001) were all significantly
higher in HF compared to LF after 3 days on the diet. B. After 1 week on the diet plasma protein levels of ApoA-IV were significantly greater in HF fed
mice compared with LF (P,0.01). There was no significant difference in haptoglobin or aACT protein levels between mice on HF vs. LF diets after 1
week. C. After 16 weeks on the diet there was significantly greater level of haptoglobin protein in plasma from HF compared to LF (P,0.01), there
was no significant difference in the levels of ApoA-IV or aACT in HF compared to LF (n = 6–8). D. Alpha-1-antichymotrypsin (aACT) plasma protein
levels were significantly greater in HF compared to LF (P,0.01) and PF (P,0.001) at 3 days. There were no significant differences in aACT plasma
protein levels after 1 week. E. ApoA-IV plasma protein was significantly increased in HF compared to LF at 3 days (P,0.001). At 1 week ApoA-IV
plasma protein levels were higher in HF compared to both LF (P,0.001) and PF (P,0.05). The amount of ApoA-IV protein was also greater in plasma
from PF mice compared to LF (P,0.01) after 1 week. F. Levels of haptoglobin protein in plasma from HF mice were significantly greater at 3 days
compared to LF (P,0.05). There was no significant difference in plasma protein levels of haptoglobin between the different diets after 1 week (n =
6–8).
doi:10.1371/journal.pone.0106159.g007
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A&B). IL-6 gene expression was undetectable after 3 days on diet
in both LF and HF fed mice. TNFa gene expression showed no
difference between HF and LF mice at 3 days and 12 weeks but
was increased after 16 weeks (Fig 11C). Oil red O staining
revealed lipid accumulation in muscle after 12 weeks of HF
feeding (Fig 11D). Muscle IL-1b, IL-6 and TNFa all showed
significant increases in expression on the LF diet with time
(Fig 11E&F). The increase in IL-6 could not be represented as
fold change compared to expression at 3 days as IL-6 gene
expression at that time was undetectable (Fig 11B).
Macrophage area and inflammatory marker gene
expression in WAT
Macrophage area identified by F4/80 immunostaining in-
creased after 8 weeks on the HF diet but was highly variable and
approached statistical significance after 16 weeks on diet
(P=0.058) (Fig 12A). A small increase in IL-1b was found after
3 days on a HF diet (P=0.06) (Fig 12B) and IL-6 was up-
regulated at this time (P,0.05) (Fig 12C). None of the other genes
tested, TNFa, CXCL-1, F4/80, MRC-1, IL-10, ARG showed
changes in the HF mice relative to the LF mice after 3 days or 1
week on diet but all genes tested showed an increase in expression
after 16 weeks on a HF diet (Fig 12C–I). Thus, the majority of
these genes showed increases over time on a HF diet (data not
shown). ARG gene expression showed an increase in LF fed mice
over time (P,0.05) (12J), IL-6 gene expression was increased on a
LF diet (P,0.01) (12K) and IL-1b was significantly increased on a
LF diet (P,0.01) (12 L).
Discussion
The present results show that the inflammatory response to a HF
diet develops in distinct stages; the first occurs within 3 days and
correlates with an acute phase response, probably resulting from an
acute and transient inflammation and activation of Kupffer cells in
the liver, and the second between 12 and 16 weeks on the HF diet
occurs when inflammation in WAT and muscle becomes apparent.
Between these times i.e. between 1 and 12 weeks on the diet, glucose
tolerance remains relatively stable and markers of inflammation are
not detectable. Nonetheless, relatively low levels of activation of some
markers of inflammation are seen inWAT after 3 days on a HF diet.
However, there was no measureable influx of macrophages to WAT
at 3 days arguing against a significant role for WAT inflammation at
this time. These data are in contrast to studies showing a gradual
increase in inflammation and glucose intolerance during the early
stages of obesity [19]. The results of the present study point to distinct
responses to HF feeding, related initially to nutritional challenge,
primarily in the liver and latterly to increased adiposity and increased
inflammation in WAT and muscle rather than gradual changes over
time. Interestingly, circulating leptin levels are increased at 3 days on
a HF diet indicating that the nutritional overload has been
recognised [25], but are unchanged after 1 week on a HF diet,
although body fat is significantly increased, indicating that
nutritional overload, at this time, no longer evokes a leptin response
and adiposity hasn’t increased sufficiently to do so either.
Figure 8. A. Plasma levels of IL-6 were increased after 3 days on a HF
diet (P,0.05) but were unchanged after 1 week and 16 weeks on diet.
B. Plasma levels of TNFa were not significantly different at any of the
time points tested but individual measurements were variable. C. As
with TNFa plasma levels of IL -1b were not significantly different at any
of the time points tested and individual measurements were variable
particularly in HF fed mice after 3 days on diet (n = 6–8).
doi:10.1371/journal.pone.0106159.g008
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Data from PF mice at 3 days and 1 week indicate that the
relative influence of diet composition and increased caloric intake,
on diet-induced changes, differs at these times. Both diet
composition and increased caloric intake appear to play roles in
increasing body weight, adiposity and liver lipid levels at both 3
days and 1 week after HF feeding. However, diet induced glucose
Figure 9. A. SerpinA3N gene expression in the liver was significantly up-regulated in a HF diet at all times tested 3 days (P,0.01), 1 week (P,0.001)
and 16 weeks (P,0.01). B. Haptoglobin gene expression was unchanged in HF fed mice liver after 3 days on diet but was increased after 1 week (P,
0.01) and 16 weeks (P,0.01). C. SAA gene expression was significantly higher on a HF diet after 3 days (P,0.01) and 1 week (P,0.001) but was not
different after 16 weeks. D. ApoA-IV gene expression was significantly down-regulated in the liver of HF fed mice after 3 days (P,0.05) and 1 week
(P,0.01) on diet but was unchanged after 16 weeks on diet. E. In comparison ApoA-IV gene expression was significantly up-regulated in the ileum of
HF fed mice after 3 days, 1 week and 16 weeks on diet (P,0.05). F. SerpinA3N gene expression in the liver was significantly down-regulated with time
on a LF diet between 3 days and 16 weeks (P,0.001). Units are fold expression changes between experimental groups relative to B2M and calculated
from the DDCt values (n = 6–8).
doi:10.1371/journal.pone.0106159.g009
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intolerance at 3 days appears to be due to the composition of the
HF diet but this changes to caloric intake by 1 week indicating a
relatively rapid switch in the mechanism for the induction of
insulin insensitivity from dietary fat to overconsumption within this
timeframe.
In the present study we utilised plasma proteomics to identify
changes in circulating proteins in response to the HF diet and
identified numerous changes after 3 days on the HF diet.
Surprisingly, most of the proteins identified were indicative of an
acute phase response which coincided with the early peak in
glucose intolerance. The acute phase response was not apparent
after 1 week on HF diet and glucose tolerance also improved at
this time. Nonetheless, data from PF mice show that the induction
of the acute phase response at 3 days appears to be due to
increased caloric intake rather than composition of the HF diet,
while glucose intolerance at 3 days was linked to the composition
of the diet. These data indicate separate causative mechanisms for
these events.
The acute phase response is defined as a systemic change that
occurs in response to injury or inflammation, which can be split
into two major effects; alterations in the concentration of a number
of plasma proteins and certain physiological and behavioural
modifications. It plays a fundamental role in avoiding the harmful
effects of external challenges and pathogenic events in mammals
with the function of re-establishing homeostasis [26] and is
principally activated by raised levels of IL-6 [27]. In the present
study circulating levels of IL-6 are elevated after 3 days but are not
different after 1 week on a HF diet. Nonetheless, circulating levels
of IL-1b and TNFa are not different in HF fed mice at any time
tested. The values for these two inflammatory markers are highly
variable in HF mice, particularly after 3 days on a HF diet,
indicating that the timing of their peak values varies between
individual animals; a finding which is typical of an acute
inflammatory response [26]. The higher levels of circulating IL-
6 and changes in a number of acute phase proteins in HF fed mice
in the present study are indicative of a rapid and transient
inflammatory response to a HF diet that occurs during the first 3
days of feeding. The source of this inflammation is not clearly
identifiable as only one anti-inflammatory gene is down-regulated
in the liver and two pro-inflammatory genes are marginally up-
Figure 10. A. The area of F4/80 staining in the liver measured as arbitrary units (AU) was significantly increased in HF fed mice at all the time points
tested (P,0.01) at 3 days and (P,0.001) at all other time points. Values appeared to peak at 4 weeks on the HF diet. Representative images of F4/80
staining (brown) for HF and LF fed mice after 1 week on diet. Mag X 200. B. MRC-1 gene expression was significantly decreased after 3 days on a HF
diet (P,0.001) but was unchanged after 1 week and 16 weeks. None of the other genes tested Il-1b, IL-6, TNFa, CXCL1, F4/80, MRC-1, ARG and ITgax
showed any change with time on a HF diet. IL-10 expression was undetectable (data not shown) (n = 6-8). C. IL-1b gene expression in the liver is up-
regulated between 3 days and 16 weeks on a LF diet (P,0.05). Units are fold expression changes between experimental groups relative to B2M and
calculated from the DDCt values (n = 6–8).
doi:10.1371/journal.pone.0106159.g010
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regulated in WAT. However, the clear increase in Kupffer cell
area seen in the liver and the absence of an increase in
immunoreactive macrophage area seen in WAT together with
previously reported transcriptomic data showing a global increase
in pro-inflammatory gene expression in the liver [18] argues for a
very early hepatic inflammatory response. This contrasts with both
WAT and muscle pro- and anti-inflammatory gene markers which
were markedly up-regulated only after 12–16 weeks on HF diet.
Nonetheless, gene expression of markers of inflammation in the
liver did not increase at any of the times studied despite an
increase in total immunoreactive macrophage area in HF fed mice
at all the time points tested.
Despite the increase in acute phase proteins in plasma and
increased gene expression of acute phase proteins in the liver in the
present study, no obvious related behavioural changes were noted
in HF fed mice apart from a decrease in food intake to around
85% of the weight of food eaten by LF mice after the first 2 days
on diet. This decline in food intake seen in HF fed rodents has
been considered as a compensatory mechanism related to an
attempt to maintain energy balance, but the results of the present
study could point to behavioural changes elicited by the acute
phase response. Nonetheless, the intake of the HF fed animals does
not increase once the acute phase response subsides indicating that
other mechanisms continue to drive this decrease in intake.
In our study the analysis of acute phase proteins in liver and
inflammatory marker gene expression in liver, muscle and WAT
over time show the importance of age-matched control groups
with the expression levels of several genes increasing with time
including IL-1b in the liver, ARG, IL-1b and IL-6 in WAT and
IL-1b and TNFa in muscle. The changes over time in the muscle
are particularly notable with an approximately 10 fold increase in
expression over the 16 weeks of the experiment. Lack of
Figure 11. A. IL-1b gene expression in muscle was unchanged after 3 days of HF diet but was up-regulated at 12 week (P,0.001) and 16 weeks (P,
0.01) B. IL-6 gene expression was not detected (ND) after 3 days on a HF diet but was up-regulated after 12 week (P,0.01) and 16 weeks (P,0.001) C.
TNFa gene expression was unaffected by a HF diet at 3 days and 12 weeks but was up-regulated at 16 weeks (P,0.001) Units are fold expression
changes between experimental groups relative to GAPDH and calculated from the DDCt values. D. Oil red O staining showed an increase in muscle
lipid after 12 weeks on HF diet. Mag X 100 (n = 6–8). E IL-1b gene expression in muscle is strongly up-regulated between 3 days and 1 week (P,0.001)
and between 3 days and 16 weeks (P,0.001) on a LF diet. F. TNFa gene expression in muscle is up-regulated over time on a LF diet between 3 days
and 1 week (P,0.001) and between 3 days and 16 weeks (P,0.05). Units are fold expression changes between experimental groups relative to
GAPDH and calculated from the DDCt values (n = 6–8).
doi:10.1371/journal.pone.0106159.g011
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appropriate LF controls can result in increases in gene expression
with time being inadvertently overlooked or becoming solely
attributed to the effects of the HF diet.
In contrast to haptoglobin and alpha-1-antichymotrypsin, the
increased level of the putative acute phase protein, ApoA-IV at 1
week is due to both diet composition and increased caloric intake
demonstrating a division between ApoA-IV and other acute phase
proteins confirmed by the up-regulation of gene expression in the
ileum rather than the liver. Higher gene expression of ApoA-IV in
the ileum in response to a HF diet is not unexpected, as increased
chylomicron formation is known to up-regulate the expression of
this gene [28]. Several functions have been ascribed to apoA-1V
besides lipid absorption including reverse cholesterol transport
[29], appetite inhibition [30] and enhanced insulin secretion [31].
Indicating its potential importance in countering HF induced
metabolic dysfunction.
The data from the present study, particularly the identification
of an early acute phase response, confirms the role of the innate
immune system in the initial reaction to HF diet. However,
another study using genetically immuno-compromised and mac-
rophage depleted mice also shows early insulin insensitivity [15]
indicating that the inflammation and acute phase response may be
secondary to the metabolic injury caused by the HF diet and not
causative. In comparison, studies using liposome–encapsulated
clodronate to deplete Kupffer cells show that the alleviation of
early, within 3 days of HF feeding, liver inflammation can lessen
the subsequent development of obesity and insulin insensitivity.
The results of the present study show that the increase in glucose
intolerance after 3 days on the HF diet is due to diet composition,
while the acute phase response appears to be due to increased
caloric intake, demonstrating that while the two effects are
coincidental they are mechanistically unrelated. These data also
support the contention that early, within days of HF feeding,
insulin insensitivity may occur in the absence of inflammation.
The early peak in glucose intolerance seen in the present study
has not been noted in other studies, for example in one study
glucose tolerance at 3 days and 10 weeks was described as
comparable [15]. There may be differences in experimental
approaches that may explain this. Some studies report early
hyperphagia seen in the HF fed mice when they were switched
from chow to the semi-purified diet [15]. This is almost certainly
due to the increased palatability of the semi-purified HF diet
which also contains relatively high levels of sucrose. More recently
a study reported no discernible increase in insulin insensitivity
between 3 days and 12 weeks on HF diet [17] but this study also
compared chow with a HF diet and issues of palatability and
differences in intake could obscure the relatively high glucose
intolerance seen after 3 days on a HF diet in the present study.
The comparison of the effects of a semi-purified HF diet with a
chow diet rather than with a semi-purified LF diet can show
different changes in metabolic parameters [32]. Indeed chow has
been found to be protective against the development of adiposity
and insulin insensitivity probably due to its high fibre content [33].
Nonetheless, we recognise that in the present study the LF and HF
semi-purified diets contain variable amounts of sucrose as well as
fat which may lead to metabolic imbalances. The level of sucrose
in the LF diet is higher than that in the HF diet so any effects of
sucrose alone on plasma glucose levels should be decreased in the
HF diet and any metabolic effects seen should be due to the
increased fat content of the diet. Even so, this does not discount
the fact that dietary fat and sucrose may act synergistically.
The induction of insulin insensitivity seen in humans after
intralipid infusion is not accompanied by inflammation [34]
contrasting with the increase seen in circulating TNFa after a
single HF meal [35]. These studies indicate that both lipid
overload and inflammation can play roles in the induction of
insulin insensitivity. Nonetheless, in the present study circulating
levels of TAG were lower in HF mice and NEFA levels were
unchanged. Only LDL and HDL cholesterol levels were higher at
3 days and 16 weeks showing a correlation with the acute phase
response, tissue inflammation and glucose intolerance. HDL
cholesterol has been shown to be habitually reduced in inflam-
mation and the acute phase response in contrast to the results of
the present study [36] demonstrating one factor that makes the
inflammation and acute phase response seen after HF feeding in
the present study atypical.
In conclusion, a HF diet appears to cause a rapid and transient
inflammation which results in an acute phase response, the
purpose of which is to limit inflammation induced damage. A HF
diet may trigger inflammation directly via activation of TLR4 or
indirectly via changes in the gut microbiota and leakage of LPS
into the circulation. The data presented in the present study
indicate that activation of the innate immune system is a primary
event in the development of obesity and metabolic disease [37], as
evidenced by an acute phase response, but that this early
inflammation is rapidly resolved. The second phase of inflamma-
tion in the muscle and WAT causes a more intractable and
persistent inflammation which is probably linked to lipid overload
and lipotoxicity in WAT and muscle [38] Nonetheless, it remains
to be seen how the first phase in inflammation and glucose
intolerance contributes to the subsequent development of obesity
and insulin insensitivity and whether strains of mice that are less
susceptible to a HF diet also mount such a response. This acute
reaction to a HF diet in terms of glucose intolerance and the acute
phase response may be indicative of a susceptibility to developing
obesity and insulin insensitivity.
Figure 12. A. The area of F4/80 staining in the WAT measured as arbitrary units (AU) was increased in HF fed mice at 12 and 16 weeks compared to
the LF diet and almost reached significance at 16 weeks (P=0.058). B. IL-1b gene expression in white adipose tissue (WAT) was slightly up-regulated
after 3 days of HF diet but was also below the level considered to be significant (P= 0.06) and was unchanged at 1 week and up-regulated at 16
weeks (P,0.05). C. IL-6 gene expression was up-regulated after 3 days on a HF diet (P,0.05), unchanged after 1 week and marginally up-regulated at
16 weeks (P= 0.054). D. TNFa gene expression was unchanged after 3 days and 1 week on HF diet but was up-regulated at 16 weeks (P,0.001). E.
CXCL-1 gene expression was unchanged at 3 days and 1 week on a HF diet but was up-regulated after 16 weeks (P,0.001). F. F4/80 gene expression
was unchanged after 3 days and 1 week on a HF diet and up-regulated 16 weeks (P,0.01) G.MRC-1 gene expression was unchanged after 3 days and
1 week of HF diet but was up-regulated 16 weeks (P,0.01) H. IL-10 gene expression was unchanged after 3 days and 1 week on a HF diet and was
up-regulated at 16 weeks (P,0.01) I. ARG gene expression was unchanged after 3 days and 1 week of HF diet but was up-regulated 16 weeks (P,
0.01). J ARG gene expression in WAT is unchanged between 3 days and 1 week and up-regulated between 3 days and 16 weeks (P,0.05) on a LF diet.
K. IL-6 gene expression in WAT is unchanged between 3 days and 1 week and up-regulated between 3 days and 16 weeks on a LF diet (P,0.01). L. IL-
1b gene expression in WAT is unchanged between 3 days and 1 week and up-regulated between 3 days and 16 weeks (P,0.01) on a LF diet. Units are
fold expression changes between experimental groups relative to B2M and calculated from the DDCt values (n = 6–8).
doi:10.1371/journal.pone.0106159.g012
Glucose Intolerance in C57Bl/6 Mice
PLOS ONE | www.plosone.org 18 August 2014 | Volume 9 | Issue 8 | e106159
Acknowledgments
Christine Grant, Gail Hempseed, Amanda C. Morris, Phyllis Nicol,
Andrew J. Farquharson and Susan M. Hay, RINH University of Aberdeen
are acknowledged for their expert and invaluable technical input. We
would also like to thank Biomathematics and Statistics Scotland (BioSS) for
expert advice on statistical analysis.
Author Contributions
Conceived and designed the experiments: LMW FMC JED CK NHWDR
TK HTN I-LS SRG AT. Performed the experiments: LMW FMC JED
CK NH WDR TK HTN I-LS SRG AT. Analyzed the data: LMW FMC
JED CK NH WDR TK HTN I-LS SRG AT. Contributed reagents/
materials/analysis tools: LMW FMC JED CK NH WDR TK HTN I-LS
SRG AT. Wrote the paper: LMW.
References
1. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation
in fat plays a crucial role in the development of obesity-related insulin resistance.
J Clin Invest 112: 1821–1830.
2. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444: 860–
867.
3. Davis JE, Gabler NK, Walker-Daniels J, Spurlock ME (2008) Tlr-4 deficiency
selectively protects against obesity induced by diets high in saturated fat. Obesity
(Silver Spring) 16: 1248–1255.
4. Caricilli AM, Nascimento PH, Pauli JR, Tsukumo DM, Velloso LA, et al. (2008)
Inhibition of toll-like receptor 2 expression improves insulin sensitivity and
signaling in muscle and white adipose tissue of mice fed a high-fat diet.
J Endocrinol 199: 399–406.
5. Kleinridders A, Schenten D, Konner AC, Belgardt BF, Mauer J, et al. (2009)
MyD88 signaling in the CNS is required for development of fatty acid-induced
leptin resistance and diet-induced obesity. Cell Metab 10: 249–259.
6. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, et al.
(2010) Metabolic syndrome and altered gut microbiota in mice lacking Toll-like
receptor 5. Science 328: 228–231.
7. Vessby B, Uusitupa M, Hermansen K, Riccardi G, Rivellese AA, et al. (2001)
Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity
in healthy men and women: The KANWU Study. Diabetologia 44: 312–319.
8. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, et al. (2007) Metabolic
endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761–1772.
9. Wright LE, Brandon AE, Hoy AJ, Forsberg GB, Lelliott CJ, et al. (2011)
Amelioration of lipid-induced insulin resistance in rat skeletal muscle by
overexpression of Pgc-1beta involves reductions in long-chain acyl-CoA levels
and oxidative stress. Diabetologia 54: 1417–1426.
10. Unger RH, Clark GO, Scherer PE, Orci L (2010) Lipid homeostasis, lipotoxicity
and the metabolic syndrome. Biochim Biophys Acta 1801: 209–214.
11. Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, et al. (2005) Local and
systemic insulin resistance resulting from hepatic activation of IKK-beta and
NF-kappaB. Nature Med 11: 183–190.
12. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, et al. (2005) IKK-beta
links inflammation to obesity-induced insulin resistance. Nature Med 11: 191–
198.
13. Kim F, Pham M, Maloney E, Rizzo NO, Morton GJ, et al. (2008) Vascular
inflammation, insulin resistance, and reduced nitric oxide production precede
the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 28:
1982–1988.
14. Thaler JP, Yi CX, Schur EA, Guyenet SJ, Hwang BH, et al. (2012) Obesity is
associated with hypothalamic injury in rodents and humans. J Clin Invest 122:
153–162.
15. Lee YS, Li P, Huh JY, Hwang IJ, Lu M, et al. (2011) Inflammation Is Necessary
for Long-Term but Not Short-Term High-Fat Diet-Induced Insulin Resistance.
Diabetes. 60: 2474–2483.
16. Wiedemann MS, Wueest S, Item F, Schoenle EJ, Konrad D (2013) Adipose
tissue inflammation contributes to short-term HFD-induced hepatic insulin
resistance. Am J Physiol Endocrinol Metab. 305 E388–395.
17. Turner N, Kowalski GM, Leslie SJ, Risis S, Yang C, et al. (2013) Distinct
patterns of tissue-specific lipid accumulation during the induction of insulin
resistance in mice by high-fat feeding. Diabetologia 56: 1638–1648.
18. Radonjic M, de H Jr, van Erk MJ, van Dijk KW, van den Berg SA, et al. (2009)
Genome-wide mRNA expression analysis of hepatic adaptation to high-fat diets
reveals switch from an inflammatory to steatotic transcriptional program. PLoS
One 4: e6646.
19. Kleemann R, van EM, Verschuren L, van den Hoek AM, Koek M, et al. (2010)
Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin
resistance. PLoS One 5: e8817.
20. Lanthier N, Molendi-Coste O, Horsmans Y, van RN, Cani PD, et al. (2010)
Kupffer cell activation is a causal factor for hepatic insulin resistance.
Am J Physiol Gastrointest Liver Physiol 298: G107–G116.
21. Lanthier N, Molendi-Coste O, Cani PD, van RN, Horsmans Y, et al. (2011)
Kupffer cell depletion prevents but has no therapeutic effect on metabolic and
inflammatory changes induced by a high-fat diet. FASEB J 25: 4301–4311.
22. Toye AA, Lippiat JD, Proks P, Shimomura K, Bentley L, et al. (2005) A genetic
and physiological study of impaired glucose homeostasis control in C57BL/6J
mice. Diabetologia 48: 675–686.
23. Atkinson KE (1989) An Introduction to Numerical Analysis. John Wiley & Sons,
New York: ISBN 978-0-471-50023-0.
24. Campbell FM, Rucklidge GJ, Reid MD, Cantlay L, Robins SP (2010)
Identification of damaged proteins in human serum using modified Ehrlich’s
reagent to target protein-bound pyrroles. Anal Biochem 398: 76–82.
25. Chin-Chance C, Polonsky KS, Schoeller DA (2000) Twenty-four-hour leptin
levels respond to cumulative short-term energy imbalance and predict
subsequent intake. J Clin Endocrinol Metab 85: 2685–2691.
26. Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses
to inflammation. N Engl J Med 340: 448–454.
27. Gauldie J, Richards C, Northemann W, Fey G, Baumann H (1989) IFN beta 2/
BSF2/IL-6 is the monocyte-derived HSF that regulates receptor-specific acute
phase gene regulation in hepatocytes. Ann N Y Acad Sci 557: 46–58.
28. Rodriguez MD, Kalogeris TJ, Wang XL, Wolf R, Tso P (1997) Rapid synthesis
and secretion of intestinal apolipoprotein A-IV after gastric fat loading in rats.
Am J Physiol 272: R1170–R1177.
29. Stan S, Delvin E, Lambert M, Seidman E, Levy E (2003) Apo A-IV: an update
on regulation and physiologic functions. Biochim Biophys Acta 1631: 177–187.
30. Tso P, Liu M (2004) Apolipoprotein A-IV, food intake, and obesity. Physiol
Behav 83: 631–643.
31. Wang F, Kohan AB, Kindel TL, Corbin KL, Nunemaker CS, et al. (2012)
Apolipoprotein A-IV improves glucose homeostasis by enhancing insulin
secretion. Proc Natl Acad Sci U S A 109: 9641–9646.
32. Benoit B, Plaisancie P, Awada M, Geloen A, Estienne M, et al. (2013) High-fat
diet action on adiposity, inflammation, and insulin sensitivity depends on the
control low-fat diet. Nutr Res 33: 952–960.
33. Mirhashemi F, Scherneck S, Kluth O, Kaiser D, Vogel H, et al. (2011) Diet
dependence of diabetes in the New Zealand Obese (NZO) mouse: total fat, but
not fat quality or sucrose accelerates and aggravates diabetes. Exp Clin
Endocrinol Diabetes 119: 167–171.
34. Hoeg LD, Sjoberg KA, Jeppesen J, Jensen TE, Frosig C, et al. (2011) Lipid-
induced insulin resistance affects women less than men and is not accompanied
by inflammation or impaired proximal insulin signaling. Diabetes 60: 64–73.
35. Nappo F, Esposito K, Cioffi M, Giugliano G, Molinari AM, et al. (2002)
Postprandial endothelial activation in healthy subjects and in type 2 diabetic
patients: role of fat and carbohydrate meals. J Am Coll Cardiol 39: 1145–1150.
36. Jahangiri A (2010) High-density lipoprotein and the acute phase response. Curr
Opin Endocrinol Diabetes Obes 17: 156–160.
37. Jin C, Flavell RA (2013) Innate sensors of pathogen and stress: linking
inflammation to obesity. J Allergy Clin Immunol 132: 287–294.
38. Unger RH, Clark GO, Scherer PE, Orci L (2010) Lipid homeostasis, lipotoxicity
and the metabolic syndrome. Biochim Biophys Acta 1801: 209–214.
Glucose Intolerance in C57Bl/6 Mice
PLOS ONE | www.plosone.org 19 August 2014 | Volume 9 | Issue 8 | e106159
